igf-1 lr3 human clinical trial 1MG Research Peptide Recombinant Human LR3-IGF-1 Protein (MG)(Active)
Description
PMID 8995214
doi: 10.3390/nu16060766
How does the Clarify & Control Protocol help
A 2009 study looking at dosing rats with oral BPC-157 found that the effectiveness of the peptide therapy was certainly present and that positive effectiveness was present
You S, Ma Z, Zhang P, Xu W, Zhan C, Sang N, et al
Antioxidants 14 (6), 617
